体内注射器市场研究报告按应用（糖尿病管理、癌症治疗、自身免疫性疾病、疼痛管理）、按类型（可穿戴注射器、贴片注射器、智能注射器）、按最终用途（医院、家庭护理场所、专科诊所）、按给药方式（皮下、肌内、静脉注射）和按区域（北美、欧洲、南美、亚太地区、中东和非洲）-预测2034
ID: MRFR/HC/39522-HCR | 100 Pages | Author: Rahul Gotadki| August 2025
| Report Attribute/Metric | Details |
| Market Size 2024 | 5.81 (USD Billion) |
| Market Size 2025 | 6.19 (USD Billion) |
| Market Size 2034 | 10.85 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 6.44 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Market Forecast Units | USD billion |
| Key Companies Profiled | Sanofi, Abbvie, Insulet Corporation, Medtronic, Syringe Technologies, Mylan, Fresenius Kabi, Terumo, Eli Lilly, Johnson and Johnson, Roche, BD, Novartis, Amgen, West Pharmaceutical Services |
| Segments Covered | Application, Type, End Use, Mode of Administration, Regional |
| Key Market Opportunities | Rising demand for self-administration, Growth in chronic disease prevalence, Advancements in drug delivery technology, Increasing investment in wearable devices, and Expansion in emerging markets. |
| Key Market Dynamics | Rising chronic disease prevalence, Growing patient compliance focus, Technological advancements in delivery, Increasing R investments, Expanding aging population |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ):
The On-body Injector Market is expected to be valued at 10.85 USD billion in 2034.
The expected CAGR for the On-body Injector Market is 6.44% from 2025 to 2034.
North America is projected to have the largest market value of 3.5 USD billion in 2032.
The market value for the Diabetes Management application is expected to reach 2.35 USD billion in 2032.
Key players include Sanofi, Abbvie, Insulet Corporation, Medtronic, and Roche, among others.
The Cancer Treatment application is projected to be valued at 2.0 USD billion in 2032.
The APAC region shows significant growth potential, expecting to reach a market value of 2.3 USD billion by 2032.
The market value for the Autoimmune Disorders application is anticipated to be 1.85 USD billion in 2032.
The Pain Management application is expected to grow to a market value of 2.8 USD billion by 2032.
The market value for Europe is expected to be 2.2 USD billion in 2032.
Comments
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
